GINKGO BIOWORKS HOLDINGS INC (DNA) Stock Earnings & Estimates
USA - New York Stock Exchange - NYSE:DNA - US37611X2099 - Common Stock
8.24 USD
0 (0%)
8.2412 USD
+0 (+0.01%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 477.7M 52.23% | 251.455M -47.36% | 227.043M -9.71% | 175.7M -22.61% | 188.49M 7.28% | 244.12M 29.51% | 299.36M 22.63% | 372.79M 24.53% | 469.55M 25.96% | 601.05M 28.01% | 734.37M 22.18% | |
| EBITDA YoY % growth | -2.12B -17.83% | -505.514M 76.16% | -420.29M 16.86% | -156.553M 62.75% | -72.013M 54.00% | 14.14M 119.64% | 40.4M 185.71% | 44.44M 10.00% | 59.59M 34.09% | 93.93M 57.63% | 153.52M 63.44% | |
| EBIT YoY % growth | -2.163B -18.28% | -576.021M 73.37% | -483.31M 16.10% | -316.297M 34.56% | -271.912M 14.03% | -270.19M 0.63% | -253.51M 6.17% | -205.03M 19.12% | -140.39M 31.53% | -55.55M 60.43% | 19.19M 134.55% | |
| Operating Margin | -452.75% | -229.08% | -212.87% | -180.02% | -144.26% | -110.68% | -84.68% | -55.00% | -29.90% | -9.24% | 2.61% | |
| EPS YoY % growth | -49.20 -512.86% | -18.80 61.79% | -8.94 52.45% | -5.70 36.23% | -4.52 20.73% | -3.99 11.73% | -0.10 97.47% | -0.01 90.00% | 0.10 1,100.00% | N/A | N/A |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.47 26.27% | -1.09 35.07% | -1.13 -2.84% | -1.17 19.20% | -1.89 -28.08% |
| Revenue Q2Q % growth | 37.562M -14.33% | 43.329M -10.33% | 45.804M -7.66% | 48.076M 23.79% | 62.267M 65.77% |
| EBITDA Q2Q % growth | -39.693M -4.12% | -24.291M 64.92% | -20.352M 40.71% | -26.578M 38.03% | -19.796M 50.13% |
| EBIT Q2Q % growth | -84.517M 16.44% | -73.326M 13.34% | -75.952M -15.99% | -78.78M 10.70% | -33.936M 59.85% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | -1.45 -54.26% | -1.25 | -0.20 | -15.78% |
| Q2 2025 Q2Q % growth | -1.10 60.71% | -1.58 | 0.48 | 30.48% |
| Q1 2025 Q2Q % growth | -1.68 47.50% | -1.79 | 0.11 | 6.02% |
| Q4 2024 Q2Q % growth | -2.00 54.55% | -1.79 | -0.21 | -11.88% |
| Q3 2024 Q2Q % growth | -0.94 85.31% | -2.75 | 1.81 | 65.88% |
| Q2 2024 Q2Q % growth | -2.80 22.22% | -3.15 | 0.35 | 11.14% |
| Q1 2024 Q2Q % growth | -3.20 27.27% | -3.37 | 0.17 | 4.95% |
| Q4 2023 Q2Q % growth | -4.40 -22.22% | -3.91 | -0.49 | -12.66% |
| Q3 2023 Q2Q % growth | -6.40 60.98% | -3.46 | -2.94 | -84.83% |
| Q2 2023 Q2Q % growth | -3.60 79.07% | -3.41 | -0.19 | -5.72% |
| Q1 2023 Q2Q % growth | -4.40 63.33% | -3.64 | -0.76 | -21.01% |
| Q4 2022 Q2Q % growth | -3.60 90.91% | -8.43 | 4.83 | 57.28% |
| Q3 2022 Q2Q % growth | -16.40 -583.33% | -11.96 | -4.44 | -37.14% |
| Q2 2022 Q2Q % growth | -17.20 | -1.75 | -15.45 | -882.56% |
| Q1 2022 Q2Q % growth | -12.00 | -1.35 | -10.65 | -791.18% |
| Q4 2021 Q2Q % growth | -39.60 | -1.75 | -37.85 | -2,162.17% |
| Q3 2021 Q2Q % growth | -2.40 | -1.41 | -0.99 | -69.73% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 38.837M -56.39% | 39.239M | -402K | -1.02% |
| Q2 2025 Q2Q % growth | 49.604M -11.75% | 42.026M | 7.578M | 18.03% |
| Q1 2025 Q2Q % growth | 48.318M 27.34% | 39.083M | 9.235M | 23.63% |
| Q4 2024 Q2Q % growth | 43.847M 26.16% | 44.909M | -1.062M | -2.36% |
| Q3 2024 Q2Q % growth | 89.046M 60.65% | 45.45M | 43.596M | 95.92% |
| Q2 2024 Q2Q % growth | 56.206M -30.24% | 43.568M | 12.638M | 29.01% |
| Q1 2024 Q2Q % growth | 37.944M -52.98% | 46.504M | -8.56M | -18.41% |
| Q4 2023 Q2Q % growth | 34.755M -64.64% | 42.927M | -8.172M | -19.04% |
| Q3 2023 Q2Q % growth | 55.43M -16.52% | 48.557M | 6.873M | 14.15% |
| Q2 2023 Q2Q % growth | 80.568M -44.28% | 72.296M | 8.272M | 11.44% |
| Q1 2023 Q2Q % growth | 80.702M -52.08% | 72.397M | 8.305M | 11.47% |
| Q4 2022 Q2Q % growth | 98.3M -33.80% | 89.547M | 8.753M | 9.77% |
| Q3 2022 Q2Q % growth | 66.4M -14.43% | 60.959M | 5.441M | 8.93% |
| Q2 2022 Q2Q % growth | 144.6M 231.65% | 78.402M | 66.198M | 84.43% |
| Q1 2022 Q2Q % growth | 168.4M 281.86% | 106.74M | 61.66M | 57.77% |
| Q4 2021 Q2Q % growth | 148.5M 362.62% | 95.755M | 52.745M | 55.08% |
| Q3 2021 Q2Q % growth | 77.6M 483.46% | 46.208M | 31.392M | 67.94% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -7.09% | -14.96% | -7.46% | -6.51% |
| Revenue | -6.01% | -7.65% | -1.76% | -1.76% |